vaxneuvance
merck sharp & dohme b.v. - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pneumokokkeninfektionen - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. siehe abschnitte 4. 4 und 5. 1 für informationen zum schutz gegen spezifische pneumokokken-serotypen. the use of vaxneuvance should be in accordance with official recommendations.
visublend 0,3 mg/ml + 5 mg/ml augentropfen, lösung
visufarma - societa' per azioni, in forma abbreviata visufarma s.p.a. (1008603) - bimatoprost; timololmaleat - augentropfen, lösung - 0,3 mg/ml + 5 mg/ml - teil 1 - augentropfen, lösung; bimatoprost (30409) 0,3 milligramm; timololmaleat (12113) 6,83 milligramm
paracetalgin 500 mg filmtabletten
ratiopharm gmbh (3087881) - paracetamol - filmtablette - 500 mg - teil 1 - filmtablette; paracetamol (01212) 500 milligramm
paracetalgin 1000 mg tabletten
ratiopharm gmbh (3087881) - paracetamol - tablette - 1000 mg - teil 1 - tablette; paracetamol (01212) 1000 milligramm
visuplain 0,1 mg/ml augentropfen, lösung
visufarma - societa' per azioni, in forma abbreviata visufarma s.p.a. (1008603) - augentropfen, lösung - 0,1 mg/ml